DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for CTI BioPharma Corp. (CTIC)
« Back to company indexCTIC Chatter Timeline
Stock Ticker for CTIC
Most Active Tweeters for CTIC
| User | Tweets |
|---|---|
| @TickerReport | 1 |
| @BeefEnt | 1 |
| @Gambiste1 | 1 |
Recent Tweets for CTIC
 |
@Gambiste1 RT @BeefEnt: CTi Biopharma Corp NASDAQ: $CTIC* Health Care : Biotechnology | Small Cap BlendCompany profile BuySell Closing Price $0.826 July 4th 2019, 10:07am |
 |
@BeefEnt CTi Biopharma Corp NASDAQ: $CTIC* Health Care : Biotechnology | Small Cap BlendCompany profile BuySell Closing Price $0.826 July 4th 2019, 10:07am |
 |
@TickerReport Head to Head Analysis: BELLUS Health $BLUSF and CTI BioPharma $CTIC https://t.co/iSONSec65B July 2nd 2019, 2:07am |
 |
@ConsumerFeed CTI BioPharma $CTIC & TG Therapeutics $TGTX Head to Head Contrast https://t.co/O66JfCwFBl July 1st 2019, 5:07am |
 |
@WeekHerald CTI BioPharma $CTIC Sees Large Volume Increase https://t.co/a2kz25xYKi June 28th 2019, 9:06pm |
 |
@OlympiaReport CTI BioPharma $CTIC Sees Unusually-High Trading Volume https://t.co/H3gfxjodHe June 28th 2019, 9:06pm |
 |
@dispatchtribune CTI BioPharma $CTIC Sees Large Volume Increase https://t.co/PwBkvl9gQa June 28th 2019, 9:06pm |
 |
@SwingTradeBot 50 DMA Support today: $CTIC ... https://t.co/aW7zteKP9U June 24th 2019, 11:06am |
 |
@dakotafinancial CTI BioPharma $CTIC Stock Crosses Above 50 Day Moving Average of $0.88 https://t.co/Vk9W2yp7o9 June 21st 2019, 7:06pm |
|
@SwingTradeBot 50 DMA Support today: $CTIC $AQB ... https://t.co/aW7zteKP9U June 19th 2019, 12:06pm |
 |
@ChartMill $CTIC has a poor technical rating and the quality of the setup is also not perfect at the moment.… https://t.co/BEUwNwweJP June 17th 2019, 8:06pm |
 |
@DataTrials $CTIC Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelo… https://t.co/l3InyTDf8e June 16th 2019, 1:06pm |
 |
@SleekMoneycom CTI BioPharma $CTIC Trading Up 5.7% https://t.co/OcdJnZFdvJ #investing June 16th 2019, 7:06am |
 |
@stocknewstimes CTI BioPharma $CTIC Trading Up 5.7% https://t.co/Yf8Z7u6FmG June 16th 2019, 7:06am |
 |
@storminvestor CTI BioPharma $CTIC Trading Up 5.7% https://t.co/D11lkpXXyI #markets June 16th 2019, 7:06am |
 |
@76enz $CTIC https://t.co/H2GSr1pb3E June 14th 2019, 3:06pm |
 |
@1stOncology #CTIBioPharma to Present at the JMP Securities #LifeSciencesConference on Thursday, Jun. 20 $CTIC https://t.co/4yD2HQbZkb June 14th 2019, 8:06am |
 |
@StockNewsNow $CTIC CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Thursday, Jun. 20 https://t.co/4xQSHs5zBE June 13th 2019, 12:06pm |
 |
@StockNewsWires $CTIC: CTI BioPharma to Present at the JMP Securities Life Sciences …: https://t.co/N4nAn9ABwL June 13th 2019, 7:06am |
 |
@Allstocknews $CTIC CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Thursday, Jun. 20 From our Stock News Alerts App June 13th 2019, 7:06am |
 |
@PredatorDiaries Drug originally developed by $CTIC, I'm sure they'll take some credit for this. Leukaemia drug could 'cure' HIV,… https://t.co/SU59xHdvym June 8th 2019, 5:06am |
 |
@WatchlistN CTI BioPharma Corp $CTIC Given Average Recommendation of “Buy” by Brokerages https://t.co/pGV7IeAgC4 June 7th 2019, 10:06pm |
|
@ChartMill $CTIC is expected to show a strong growth in EPS. In the coming 2 years, the EPS will grow by 21.11% yearly.… https://t.co/vlfXVXtrFo June 5th 2019, 6:06pm |
 |
@TheMarketsDaily CTI BioPharma Corp $CTIC Receives $4.80 Average Target Price from Analysts https://t.co/Sy57t2MMwF June 5th 2019, 3:06pm |
 |
@Stock_News_Now $CTIC: New SEC Filing for CTIC: Form 8-K (No. 0000891293-19-000050): https://t.co/azLQpE8XLW June 4th 2019, 4:06pm |
|
@Allstocknews $CTIC ALERT: New CTI BioPharma Corp SEC Filing From our Stock News Alerts App June 4th 2019, 4:06pm |
 |
@filingsdb New Form 8-K filed by CTI BIOPHARMA CORP $CTIC - https://t.co/UIduekkwmD June 4th 2019, 4:06pm |
 |
@JAPhillips $CTIC looks like it might be worth keeping an eye on June 4th 2019, 1:06pm |
 |
@AmericanBanking CTI BioPharma Corp $CTIC Given Average Rating of “Buy” by Analysts https://t.co/Q74j9hXaRt #stocks May 31st 2019, 7:05am |
|
@ChartMill Based on estimates for the next 2 years, $CTIC will show a very strong growth in EPS: 21.11% on average per year.… https://t.co/Y1ibaQgKWm May 30th 2019, 5:05pm |
|
@1stOncology #CTIBioPharma to Present at the Jefferies Global #HealthcareConference on Wednesday, Jun. 5 $CTIC https://t.co/P3awrr5owo May 30th 2019, 6:05am |
|
@StockNewsNow $CTIC CTI BioPharma to Present at the Jefferies Global Healthcare Conference on Wednesday, Jun. 5 https://t.co/xsKqXcY19L May 29th 2019, 5:05pm |
|
@Allstocknews $CTIC CTI BioPharma to Present at the Jefferies Global Healthcare Conference on Wednesday, Jun. 5 From our Stock News Alerts App May 29th 2019, 7:05am |
 |
@StockTipRobot Berkshire Hathaway's janitor's cousin told me to move all human dollars into CTI BioPharma Corp. $CTIC #NotRealStockAdvice May 25th 2019, 7:05am |
|
@Stock_News_Now $CTIC: New SEC Filing for CTIC: Form S-8 (No. 0000891293-19-000048): https://t.co/GC8fgEM1oL May 23rd 2019, 4:05pm |
 |
@VisualStockRSRC $CTIC - Securities Registration: Employee Benefit Plan (s-8) https://t.co/27Q42S6vnN May 23rd 2019, 4:05pm |
|
@TickerReport CTI BioPharma $CTIC Trading Up 8.7% https://t.co/bOyGaN765C May 22nd 2019, 5:05pm |
 |
@bulletin_en Reviewing MannKind Corporation $CTIC's results https://t.co/BVLbzDtItm May 21st 2019, 2:05pm |
 |
@FlashAlert_me $ctic filed SEC form 4: Director Fischer Laurent: https://t.co/R4wLD4moZk May 20th 2019, 6:05pm |
 |
@InsiderAlertsIA $ctic: New Insider Filing on President and CEO ADAM R CRAIG: https://t.co/bVevqnxlW1 May 20th 2019, 4:05pm |
 |
@confcalltran Cell Therapeutics's President and CEO was just granted 1,300,000 options https://t.co/SeWfkezb0O $CTIC May 20th 2019, 4:05pm |
|
@76enz $CTIC 14% https://t.co/Ck0odcki9h May 20th 2019, 1:05pm |
|
@76enz $CTIC 12% May 20th 2019, 1:05pm |
|
@bulletin_en Reviewing Lexicon Pharmaceuticals Inc. $CTIC's results https://t.co/wK8w1Q0sEh May 17th 2019, 5:05pm |
|
@bulletin_en Reviewing Cellectis S.A. $CTIC's results https://t.co/uKwCukZHaW May 17th 2019, 5:05pm |
|
@bulletin_en Aratana Therapeutics Inc. $CTIC Comparison side by side https://t.co/zvNQwchtUH May 14th 2019, 11:05pm |
|
@76enz $CTIC 6% https://t.co/lZ8E04x4tW May 14th 2019, 9:05am |
|
@76enz $CTIC 5% May 14th 2019, 9:05am |
|
@DataTrials $CTIC Phase 1|Phase 2 A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppressi… https://t.co/EwCJt3wkwZ May 13th 2019, 4:05pm |
 |
@dailypoliticaln CTI BioPharma Corp $CTIC Given Consensus Recommendation of “Buy” by Analysts https://t.co/nYp8d7SMRL May 11th 2019, 3:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.